Funding (from 2014)

  • National network of Advanced Proteomics Infrastructure (NAPI) in Norway

    UiO: T. Nyman, B. Thiede, J. Pahnke, T. Fladby, F. Lund-Johansen, S. Wilson, T. Grønhaug Halvorsen
    UiB: F. Berven
    NTNU: G. Slupphaug
    UNN: T. Johansen
    NMBU: V. Eijsink

    NFR
    2019-2024 (101mKr – 10m€)

  • Establishment of comprehensive molecular diagnostics for brain tumours in kids in Norway

    Jens Pahnke
    Barnekreftforeningen Norge
    2019-2022

  • The Importance of ABC Transporters for the Pathogenesis and Treatment of Huntington’s Disease (ABC-HD)

    Jens Pahnke
    HELSE-SØR-ØST
    2019-2022 (3 years PhD position)

  • S1P and ABC transporters – synergistic treatment targets for Alzheimer´s disease (ABC-S1P)

    Kristin Paarmann
    HELSE-SØR-ØST
    2019-2022 (3 years PostDoc position)

  • Dimethyl fumarate – Repurposing a MS drug to treat AD (REPURPOSE-DMF)

    Luisa Möhle
    Nasjonalforeningen
    2019-2022 (3 years PostDoc position)

  • Short Aβ-related peptides in the pathogenesis of Alzheimer’s disease – new avenues for treatment (ShortAbeta)

    Baiba Jansone, Jenss Pānke, Henriks Biverstol
    Latvijas Zinātnes padomes
    2018-2021
    read more…
    read more in Latvian

  • PROP-AD: Propagation behaviour of peripheral amyloid-β towards brain structures: effects of the blood-brain barrier

    Jens Pahnke (coordinator), Claus Pietzrik, Danny Frenkel, Maciej Lalowski, Henrik Biverstål
    JPND – Joint Initiative in Neurodegenerative Diseases
    NFR, BMBF, CSO-MOH, AKA, SRC
    2017-2019 (1,75 million € – 3 years)
    read more…

  • Evaluation of phytopharmaca for the prevention and therapy of dementias and age-related cognitive dysfunctions

    Jens Pahnke, Ludger Wessjohann, Timothy Sharbel
    Autonomie im Alter – LSA Initiative (EFRE)
    2017-2019
    EU-flag SA-flag

  • ABC transporters as early diagnostics and treatment marker for neurodegenerative dementias – towards a personalised medicine in dementia

    Jens Pahnke
    HELSE-SØR-ØST
    2016-2019 (3 years PostDoc)

  • The role of the blood-brain barrier in Alzheimer’s disease function

    Jens Pahnke (forskerprosjekt)
    FRIMEDBIO
    NRF – Norges Forskningsrådet
    2016-2020 (7,1 million NOK – 3 years)
    read more…

  • TransportDementia forum

    Jens Pahnke
    NRF – Norges Forskningsrådet
    2015-2018 (2,0 million NOK – 3 years)
    read more…

  • NeuroGem: Identification of genes that modulate the severity of neurodegenerative diseases

    Jörg Gsponer, Paul Pavlidis, Olaf Riess, Eleonora Aronica, Jens Pahnke
    JPND – Joint Initiative in Neurodegenerative Diseases
    CIHR, ZonMW, BMBF and RCN
    2015-2018
    read more…

  • St. John’s wort as Alzheimer’s treatment – New ways of identification, exploitation and use of natural resources

    Jens Pahnke, Ludger Wessjohann, Timothy Sharbel, Stefan Posch
    SAW – Leibniz Society Grant
    2015-2018
    read more…

  • ABC transporter function in Neurodegeneration

    Jens Pahnke
    EU / UiO – Marie Curie Scientia Program
    Ádám Sike and Petra Sántha
    2015-2017

    EU-flag 

  • Benefits and detrimental effects of sequence variants of amyloid-β: towards the use of small peptides for aggregate dissolution therapy in dementia

    Jens Pahnke, Henrik Biverstål, Baiba Jansone
    RCN & EEA
    2015-2017
    read more…

  • The role of the blood-brain barrier in Alzheimer s disease: Interaction of LRP1 and ABC transporter function

    Jens Pahnke and Claus Pietrzik
    DFG PA930/12-1 and PI379/8-1
    2014-2018
    read more…

  • ADEPT drift støtte

    Jens Pahnke
    RCN246392
    2015

  • PETAD: PET imaging to assess blood-brain barrier function in Alzheimer’s disease

    Jens Pahnke and Oliver Langer
    DFG PA930/9-1 and FWF I1609-B24
    2014-2018
    read more…

     

  • Blood-brain barrier ABCG2 function in Alzheimer´s disease

    Thomas Wanek, Jens Pahnke
    LSC14-008 – Niederösterreich / Austria
    2015-2018

  • Nigerian plants for the treatment of mental disorders

    Olanrewayu Salako
    DAAD Fellowship
    2014-2016

     

  • ABC transporter activation for treatment of Alzheimer’s disease

    Jens Pahnke
    Immungenetics AG
    2012-2018

  • Establishment of patient cohorts for Multiple Sclerosis

    Jens Pahnke
    Immungenetics AG
    2012-2014

  • Defining specific phyto extracts for the treatment of Alzheimer’s disease

    Markus Krohn
    Bionorica Research Prize
    2015

     

  • Previous funding

    EU, BMBF, DFG, industry
    2002-2014
    under-construction